Company / SG&A per Share
BioLife Solutions, Inc. SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.94
FY2025
5-year range
$0.77 / $0.98
FY2021-FY2025
Trend
+6.1%
vs FY2024
Sector context
#136 of 150
Health Care
What the data says
Among 150 Health Care companies, BioLife Solutions, Inc. is in the top 9% for sg&a per share. SG&A per Share has fluctuated over the past 10 years, ranging from $0.19 in FY2018 to $0.98 in FY2023.
Based on SEC 10-K filings.
0.94 in FY2025 with a 5-year CAGR of +10.8%.
Improved from $0.98 to $0.94 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +6.6%
- 5-Year CAGR
- +10.8%
- 10-Year CAGR
- -
Sector benchmark
Top 9% in Health CareTop 9% of 150This company $0.94 Sector average $11878.17
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share increased 6.1% year-over-year.
- Ranks #136 out of 150 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2023.
- Lowest sg&a per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 4.67 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.94 | +6.1% |
| FY2024 | $0.88 | -9.9% |
| FY2023 | $0.98 | +26.8% |
| FY2022 | $0.77 | -11.7% |
| FY2021 | $0.87 | +56.3% |
| FY2020 | $0.56 | +22.4% |
| FY2019 | $0.46 | +143.9% |
| FY2018 | $0.19 | -46.7% |
| FY2017 | $0.35 | -4.7% |
| FY2016 | $0.37 | -8.4% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026